Tokyo, Nov. 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063382) titled 'Intestinal mucin and relapse in patients with ulcerative colitis in remission' on Nov. 1.
Study Type:
Observational
Primary Sponsor:
Institute - Kitasato University
Condition:
Condition - Ulcerative colitis
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To evaluate intestinal mucin at the glycan level in the colonic mucosa of patients with ulcerative colitis in remission. To examine whether its expression predicts subsequent clinical relapse.
Basic objectives2 - Others
Eligibility:
Age-lower limit - 18
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Patients aged 18 years or older who were diagnosed with and treated for ulcerative colitis at Kitasato University Hospital and underwent colonoscopy.
Key exclusion criteria - 1. Patients who have undergone or are scheduled for surgical resection for ulcerative colitis
2. Patients with ulcerative proctitis
3. Patients who cannot attend long-term follow-up
4. Pregnant or breastfeeding women
5. Patients who do not provide informed consent
Target Size - 150
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2026 Year 09 Month 15 Day
Date of IRB - 2026 Year 09 Month 16 Day
Anticipated trial start date - 2026 Year 11 Month 01 Day
Last follow-up date - 2031 Year 04 Month 30 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072412
Disclaimer: Curated by HT Syndication.
